The Brutal Math Behind the NervGen Spinal Injury Hype
A new drug offers hope for spinal cord injury recovery.
Tag: biotechnology
Davos 2026 Capital Mandates Face 5 Percent Interest Rate Realities
Key leaders will discuss health and biotechnology at WEF.
The High Stakes of the Brussels Genomic Realignment
The EU’s new gene editing regulations could reshape agriculture.
The Synthetic Pivot and the Liquidity Trap of Late 2025
Cathie Wood’s Ark Invest adapts with strategic decisions.
The Metabolic Moat Faces Its Fiscal Reckoning
Eli Lilly is poised for potential growth in the upcoming quarter.